Current Molecular Medicine · 2019 · 23 citations · 33 references
Life SciencesGeneticsImmunologyAutoimmunityImmunogeneticsInflammationAutoimmune DiseasesCytokine Gene PolymorphismGenetic Susceptibility To AutoimmunityInterleukin Gene VariantsMultiple SclerosisReceptor PolymorphismsAsthma ImmunogeneticsEnzyme-linked Immunosorbent Assay (Elisa)Genetic PolymorphismsGenetic Risk VariantsHost Genetic PolymorphismsHost Genetic VariantsInterleukin-1 Beta PolymorphismsMultiple Sclerosis Associations
BACKGROUND: Asthma is a chronic and complex inflammatory disease of the respiratory tract. Also, multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Against this background, IL-33 and IL1RL1 play a critical role in autoimmune and inflammatory disorders. Here, we explored the IL-33 serum level and two potential genetic variants in the IL33 gene and its receptor in Iranian asthma and MS patients. METHODS: This study consisted of asthma (n=140) and MS patients (n=140), and healthy subjects (n=72). Genotyping was carried out in two genetic polymorphisms, rs1342326 variant of IL-33 and rs10204137SNP variant of IL-33 receptor genes, using High- Resolution Melt Real- Time PCR based method. The level of serum IL-33 was also measured using enzyme-linked immunosorbent assay method. RESULTS: The level of IL33 was significantly higher in asthma and MS patients compared to the control group (P< 0.001- P<0.001).The frequency distribution of the genotype in rs1342326 variant of IL-33 gene in patients with asthma, MS and healthy subjects was not significantly different (P>0.05). The frequency distribution of the genotype in rs10204137 variant of IL-33 gene in MS patients and healthy subjects was significantly different (p = 0.013). CONCLUSION: Our findings demonstrated that asthma and MS patients had a higher level of IL-33, and IL-33 receptor genetic polymorphism was associated with MS. Further studies in a larger multicenter setting are needed to explore the value of this marker as a risk stratification biomarker.
33
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer, Maria Ban, Anu Kemppinen et al. · Nature · 2011 · 2.7K citations · Full text
Life Sciences, Immunology, Neurology +17